May 20, 2008
http://www1.wfubmc.edu/News/NewsARticle.htm?ArticleID=2364 - New Guidelines Say Botulinum Toxin Effective For Many Neurological Disorders, but Not Headache
http://www1.wfubmc.edu/News/NewsARticle.htm?ArticleID=2340 Primary Stroke Center re-accreditation
http://www1.wfubmc.edu/News/NewsARticle.htm?ArticleID=2287 Stroke Education Program
http://www1.wfubmc.edu/News/NewsARticle.htm?ArticleID=2264 Three Experts Join Neurology and Neurosurgery Faculty
http://www1.wfubmc.edu/News/NewsARticle.htm?ArticleID=2258 Wake Forest Physicians Elected to Medical Center Board of Directors
http://www1.wfubmc.edu/News/NewsARticle.htm?ArticleID=2255 Jonathan Bailey – Director of Neurosciences service line
http://www1.wfubmc.edu/News/NewsARticle.htm?ArticleID=2269 Michael Waid – Administrative Director of Diagnostic Neurology
~~
Winston-Salem Journal Sunday, June 29, 2008
Dr. Allison Brashear, a professor and the chairwoman of neurology at Wake Forest University Baptist Medical Center, has been honored by Park Tudor School as a nationally recognized medical researcher. Brashear is a 1979 graduate of Park Tudor School in Indiana. The Park Tudor Distinguished Alumni Award recognizes alumni who have made substantial contributions to a field of endeavor, their community and the school. Brashear was the first to show that Botulinum toxin relived spasticity in wrists and fingers were published in the New England Journal of Medicine.
~~
TSI Awards Three New Pilot Grants
The Translational Science Institute (TSI) announced three new Team Research pilot grants today. Two grants of $125,000 each were awarded to further develop a team-based, translational idea. One grant of $50,000 was awarded to a new team to help them get established as a working group and to gather pilot data.
The projects funded by the larger Team Science awards include:
Early Changes in Amyotrophic Lateral Sclerosis (ALS)
· Carol Milligan, PhD, Neurobiology and Anatomy
· James Caress, MD, Neurology
· Michael Cartwright, MD, Neurology
· Osvaldo Delbono, MD, PhD, Internal Medicine-Gerontology
· Donald Gage, PhD, Radiation Biology
· Ronald Oppenheim, PhD, Neurobiology and Anatomy
· Tom Smith, PhD, Surgery-Orthopaedics
Translational Breast Cancer Metabolomics
· Vladimir Shulaev, PhD, Virginia Tech
· Reinhard Laubenbacher, PhD, Virginia Tech
· Steve Akman, MD, Cancer Biology
· Mara Vitolins, DrPH, Public Health Sciences-Epidemiology
The Team Development award winner is:
A Systems Approach to the Discovery of Novel Targets and Biomarkers in Osteoarthritis
· Richard Loeser, MD, Molecular Medicine
· Jacquelyn Fetrow, PhD, Computer Science
· Cristin Ferguson, MD, Surgery-Orthopaedics
· Iris Leng, PhD, PHS-Biostatistical Sciences
· Cathy Carlson, DVM, PhD, University of Minnesota
Peer reviewers and the TSI Science Council evaluated a total of 37 applications, 13 Team Science proposals and 24 Team Development proposals. The current round of awardees will join 12 other teams working on translational science pilot projects funded by the TSI.
~~
Neurology
Brenner Children’s Hospital has three pediatric neurologists trained in both pediatrics and neurology. These pediatric specialists have extensive experience working with children who have muscular dystrophy, epilepsy, brain tumors, spinal cord injuries, cerebral palsy, sleep disorders, headaches and other serious neurological conditions. They also conduct research on various neurological disease, guaranteeing that children have access to the most cutting –edge treatments available.
Wake Forest’s Comprehensive Epilepsy Center is recognized internationally for the management of epilepsy. With our comprehensive approach to care, we are among the top-rated epilepsy programs in the country and the only program in western North Carolina that meets the Level IV guidelines of the National Association of Epilepsy Centers. This is the highest level of accreditation a medical center can achieve.
Wake Forest Baptist offers a full range of services from routine screening to treatment options for the most complicated cases. Our leadership in the field of epilepsy treatment allows patients early access to the newest medications through clinical trials. Our epileptologists, including specialists in pediatric epilepsy, are experts in selecting the drug combinations most suitable for each patient. When medication alone can’t control seizures, we evaluate the patients for other treatment options including surgical procedures. We offer patients the most sophisticated tests available today, including video-EEG monitoring, magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT) and neuropsychological tests which help localize the seizure focus.
Our team – including full-time epileptologists, a neurosurgeon experience in epilepsy surgery, nurse clinicians, social workers, pharmacists and neuropsychologists – work with patients to diagnose and treat the disease, which affects about one percent of the population. Researchers at the Medical Center work to find a cure for the disorder and their patients benefit from the newest therapies available.
Wake Forest Comprehensive Epilepsy Center is one of only 28 clinical sites in the country, and the only site in North Carolina or surrounding states, to utilize magnetoencephalography (MEG), an innovative, non-invasive diagnostic tool that provides valuable information about normal and abnormal function of the brain.